Tobacco use and its determinants in HIV-infected patients on antiretroviral therapy in West African countries

International Journal of Tuberculosis and Lung Disease

Volumn 13, Issue 11, 2009, Pages 1433-1439

  Jaquet, A ^a,b   Ekouevi, D K ^a,c   Aboubakrine, M ^d   Bashi, J ^e   Messou, E ^f   Maiga, M ^d   Traore, H A ^g   Zannou, M ^e   Guehi, C ^h   Ba Gomis, F O ⁱ   Minga, A ^j   Allou, G ^c   Eholie, S P ^k   Dabis, F ^a   Bissagnene, E ^k   Sasco, A J ^b  

^a HIV Epidemiology ^*  (China)

^b INSERM   (France)

^c Centre Hospitalière Universitaire de Treichville   (China)

^d HÔPITAL GABRIEL TOURÉ   (Mali)

^e Centre national hospitalier universitaire   (Benin)

^f ACONDA Centre de Prise en Charge   (China)

^g Hopital National du Point G   (Mali)

^h Unité de Soins Ambulatoires et de Conseil   (China)

ⁱ Centre Intégré de Recherche Bioclinique d'Abidjan   (China)

^j Centre Médical de Suivi de Donneurs de Sang Centre National de Transfusion Sanguine PRIMO CI   (China)

^k Service de Maladies Infectieuses et Tropicales   (China)

more..

Author keywords

Estimate; HIV AIDS; Prevalence; Sub Saharan Africa; Tobacco; Tuberculosis

Indexed keywords

CANNABIS; ANTIRETROVIRUS AGENT;

AFRICA; ANAMNESIS; ARTICLE; CANNABIS ADDICTION; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; HEALTH CARE PERSONNEL; HEALTH SURVEY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; QUESTIONNAIRE; SMOKING; ADULT; BENIN; CANNABIS SMOKING; CLINICAL TRIAL; COTE D'IVOIRE; DATA BASE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALI; MIDDLE AGED; MULTICENTER STUDY; RISK; STATISTICAL MODEL; TUBERCULOSIS;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BENIN; COTE D'IVOIRE; CROSS-SECTIONAL STUDIES; DATABASES AS TOPIC; FEMALE; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; MALI; MARIJUANA SMOKING; MIDDLE AGED; ODDS RATIO; PREVALENCE; QUESTIONNAIRES; SMOKING; TUBERCULOSIS;

EID: 73949158440     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Lewden C, Salmon D, Morlat P, et al. Causes of death among human immunodef ciency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol 2005; 34: 121-130.
2. Benard A, Tessier J F, Rambeloarisoa J, et al. HIV infection and tobacco smoking behaviour: prospects for prevention? ANRS CO3 Aquitaine Cohort, 2002. Int J Tuberc Lung Dis 2006; 10: 378-383.
3. Collins R L, Kanouse D E, Gifford A L, et al. Changes in health-promoting behavior following diagnosis with HIV: prevalence and correlates in a national probability sample. Health Psychol 2001; 20: 351-360.
4. Friis-Moller N, Weber R, Reiss P, et al. Cardiovascular disease risk factors in HIV patients\association with antiretroviral therapy. Results from the DAD study. AIDS 2003; 17: 1179-1193.
5. Gritz E R, Vidrine D J, Lazev A B, Amick B C III, Arduino R C. Smoking behavior in a low-income multiethnic HIV/AIDS population. Nicotine Tob Res 2004; 6: 71-77.
6. Centers for Disease Control and Prevention. Cigarette smoking among adults\United States 2006. MMWR 2007; 56 (RR-44) 1157-1161.
7. Saves M, Chene G, Ducimetiere P, et al. Risk factors for coronary heart disease in patients treated for human immunodef ciency virus infection compared with the general population. Clin Infect Dis 2003; 37: 292-298.
8. Sasco A J, Merrill R M, Dari I, et al. A case-control study of lung cancer in Casablanca, Morocco. Cancer Causes Control 2002; 13: 609-616.
9. Voirin N, Berthiller J, Benhaim-Luzon V, et al. Risk of lung cancer and past use of cannabis in Tunisia. J Thorac Oncol 2006; 1: 577-579.
10. World Health Organization. Guidelines for controlling and monitoring the tobacco epidemic. Geneva, Switzerland: WHO, 1998.
11. Shafey O, Eriksen M, Ross H, Mackay J. The tobacco atlas. New York, NY, USA: American Cancer Society, World Lung Foundation, 2009. http://www. tobaccoatlas.org/Accessed September 2009.
12. Koff N, Kouassi B, Horo K, et al. [Smoking in the African setting (Abidjan, Ivory coast): patient knowledge, attitude and behavior]. Rev Pneumol Clin 2004; 60: 217-222. [French] (Pubitemid 39312366)
13. Sodjinou R, Agueh V, Fayomi B, Delisle H. Obesity and cardio-metabolic risk factors in urban adults of Benin: relationship with socio-economic status, urbanisation and lifestyle patterns. BMC Public Health 2008; 8: 84. (Pubitemid 351559545)
14. Pampel F. Tobacco use in sub-Sahara Africa: estimates from the demographic health surveys. Soc Sci Med 2008; 66: 1772-1783. (Pubitemid 351380637)
15. Cherif M H. [The tobacco problem in French-speaking Africa and regional perspectives of the French-speaking African tobacco observatory]. Promot Educ 2005; (Suppl 4): S45-S47, S61. [French]
16. da Costa e Silva V L. [Health consequences of the tobacco epidemic in West African French-speaking countries and current tobacco control]. Promot Educ 2005; (Suppl 4): S7-S12 S54. [French]
17. Legresley E, Lee K, Muggli M E, Patel P, Collin J, Hurt R D. British American tobacco and the 'insidious impact of illicit trade' in cigarettes across Africa. Tob Control 2008; 17: 339-346.
18. Townsend L, Flisher A J, Gilreath T, King G. A systematic literature review of tobacco use among adults 15 years and older in sub-Saharan Africa. Drug Alcohol Depend 2006; 84: 14-27. (Pubitemid 44131494)
19. Warren C W, Jones N R, Peruga A, et al. Global youth tobacco surveillance, 2000-2007. MMWR Surveill Summ 2008; 57: 1-28.
20. Simen-Kapeu A, La Ruche G, Kataja V, et al. Tobacco smoking and chewing as risk factors for multiple human papillomavirus infections and cervical squamous intraepithelial lesions in two countries (Cote d'Ivoire and Finland) with different tobacco exposure. Cancer Causes Control 2009; 20: 163-170.
21. La Ruche G, Ramon R, Mensah-Ado I, et al. Squamous intra-epithelial lesions of the cervix, invasive cervical carcinoma, and immunosuppression induced by human immunodef ciency virus in Africa. Dyscer-CI Group. Cancer 1998; 82: 2401-2408. (Pubitemid 28283447)
22. Arcavi L, Benowitz N L. Cigarette smoking and infection. Arch Intern Med 2004; 164: 2206-2216. (Pubitemid 39452980)
23. Boschini A, Smacchia C, Di Fine M, et al. Community-acquired pneumonia in a cohort of former injection drug users with and without human immunodef ciency virus infection: incidence, etiologies, and clinical aspects. Clin Infect Dis 1996; 23: 107-113. (Pubitemid 26323804)
24. Gordin F M, Roediger M P, Girard P M, et al. Pneumonia in HIV-infected persons: increased risk with cigarette smoking and treatment interruption. Am J Respir Crit Care Med 2008; 178: 630-636.
25. Hirschtick R E, Glassroth J, Jordan M C, et al. Bacterial pneumonia in persons infected with the human immunodef ciency virus. Pulmonary Complications of HIV Infection Study Group. N Engl J Med 1995; 333: 845-851.
26. Nagappan V, Kazanjian P. Bacterial infections in adult HIV-i nfected patients. HIV Clin Trials 2005; 6: 213-228. (Pubitemid 41601133)
27. Sullivan J H, Moore R D, Keruly J C, Chaisson R E. Effect of antiretroviral therapy on the incidence of bacterial pneumonia in patients with advanced HIV infection. Am J Respir Crit Care Med 2000; 162: 64-67.
28. Dhamgaye T M. Tobacco smoking and pulmonary tuberculosis: a case-control study. J Indian Med Assoc 2008; 106: 216-219.
29. Hassmiller K M. The association between smoking and tuberculosis. Salud Publica Mex 2006; 48 (Suppl 1): S201-S216.
30. Kolappan C, Gopi P G. Tobacco smoking and pulmonary tuberculosis. Thorax 2002; 57: 964-966. (Pubitemid 35316275)